2001 Fiscal Year Final Research Report Summary
The potential radioiodinated (-)-o-iodovesamicol for diagnosing-Alzhemer's disease.
| Project/Area Number |
11670878
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Radiation science
|
|---|
| Research Institution | KANAZAWA UNIVERSITY |
|---|
Principal Investigator |
SHIBA Kazuhiro KANAZAWA UNIVERSITY, Radioisotope Center, Associated Professor, アイソトープ総合センター, 助教授 (40143929)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
MORI Hirofumi KANAZAWA UNIVERSITY, Radioisotope Center, Professor, アイソトープ総合センター, 教授 (90019604)
|
|---|
| Project Period (FY) |
1999 – 2001
|
| Keywords | Iodovesamicol / Cholinergic neurons / Acetylcholine Transporter / Alzheimer's Disease |
|---|
| Research Abstract |
We evaluated the potencies of radioiodinated (-)-o-iodovesamicol [(-)-oIV] as a selective vesicular acetylcholine transporter (VAChT) mapping agent. In vitro studies, (-)-enantiomers [(-)-ortho-iodovesamicol ((-)-OIV), (-)-meta-iodovesamicol ((-)-mIV), (-)-vesamicol] displayed a higher affinity for VAChT than (+)-enantiomer [(+)-OIV, (+)mlV, (+)-vesamicol]. (-)-OIV and (-)-mlV showed the same high affinity for VAChT as (-)-vesamicol. For sigma receptors(σ-1, σ-2), (-)-OIV (Ki = 62.2 nM ( to σ-1) and 554 nM ( to σ-2 ) ) showed a lower affinity than (-)-mlV ( Ki = 4.5 nM ( to σ-1) and 42.9 nM (to σ-2 ) ). In vivo regional brain distribution study and ex vivo autoradiographic study, the characteristics of (-)-[^<125>I]oIV accumulation is very similar to that of [^3H]vesamicol in rat brain. Displacement studies in vivo showed that the binding affinity of (-)[^<125>I]oIV for VAChT was very high and that for sigma receptors was low. Furthermore, the rate of reduction in (-)-[^<125>I]oIV accumulation (17 %) was significantly higher than that of (-) [^<125>I]mIV (10 %) in the ipsilateral cortex to the lesion (P < 0.01) in a unilateral NBM-lesioned rat. These results suggested that (-)-OIV is superior to (-)mlV as a selective vesicular acetylcholine transporter mapping agent. Radioiodinated (-)-oIV may potentially be useful for diagnosis of Alzheimer's disease.
|
